3 Do the clinical trials in Albania, and if the drug is approved, use part of the profits to set up a compassionate use program in Albania, even though setting up a distribution system and training doctors to administer the drug, monitor patients for adverse effects, and track results will entail considerable expense. Dr Abraham Hassan knew that he couldn't put off the decision any longer. AH Biotech, the Bound Brook, New Jersey-based company started by this psychiatrist-turned-entrepreneur, had developed a novel drug that seemed to promise long-term relief from panic attacks. If it gained approval from the Food and Drug Administration (FDA), it would be the company's first product. It was now time for large-scale clinical trials. But where should AH Biotech conduct those tests?

David Berger, who headed up research and development, was certain he already knew the answer to that question: Albania. 'Look, doing these trials in Albania will be quicker, easier, and a lot cheaper than doing them in the States', he pointed out. 'What's not to like?'